오피오이드 사용 장애(OUD) 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2034년)
Opioid Use Disorders Market (Drug Type: Buprenorphine, Methodone, and Naltrexone; and Route of Administration: Oral and Parenteral) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
상품코드:1552770
리서치사:Transparency Market Research
발행일:2024년 07월
페이지 정보:영문 134 Pages
라이선스 & 가격 (부가세 별도)
한글목차
오피오이드 사용 장애(OUD) 시장 - 조사 범위
TMR의 조사 보고서 "세계 오피오이드 사용 장애(OUD) 시장"은 2024년부터 2034년까지의 예측 기간 동안 시장 지표에 대한 귀중한 인사이트를 얻기 위해 과거뿐만 아니라 현재의 성장 동향과 기회를 조사합니다. 이 보고서는 2024년을 기준 연도로, 2034년을 예측 연도로 하여 2018년부터 2034년까지 전 세계 오피오이드 사용 장애(OUD) 시장의 수익과 예측을 제공합니다. 또한 2024년부터 2034년까지 세계 오피오이드 사용 장애(OUD) 시장의 연평균 성장률(CAGR %)도 제시합니다.
이 보고서는 광범위한 조사를 통해 작성되었습니다. 1차 조사에서 애널리스트는 주요 오피니언 리더, 업계 리더, 오피니언 메이커를 대상으로 인터뷰를 진행했습니다. 2차 조사에서는 주요 기업의 제품 자료, 연례 보고서, 보도 자료, 관련 자료 등을 참고하여 오피오이드 사용 장애 시장을 이해하고자 했습니다.
시장 스냅샷
2023년 시장 규모
32억 달러
2034년 시장 규모
88억 달러
CAGR
9.9%
이 보고서는 세계 오피오이드 사용 장애(OUD) 시장의 경쟁 환경을 조사하고 있습니다. 세계 오피오이드 사용 장애(OUD) 시장에서 사업을 운영하는 주요 기업들이 확인되었으며, 각 기업들은 다양한 속성으로 프로파일링되었습니다. 회사 개요, 재무 상태, 최근 동향, SWOT 등 세계 오피오이드 사용 장애(OUD) 시장에서 활동하는 주요 업체들이 이 보고서에 소개되어 있습니다.
목차
제1장 서문
제2장 가정과 조사 방법
제3장 주요 요약 : 시장
제4장 시장 개요
소개
개요
시장 역학
시장 분석과 예측, 2020-2034년
제5장 주요 인사이트
파이프라인 분석
주요 제품·브랜드 분석
주요 M&A
COVID-19에 의한 산업에 대한 영향
제6장 세계의 시장 분석과 예측 : 약제 종류별
소개와 정의
주요 조사 결과·발전
시장 금액 예측 : 약제 종류별, 2020-2034년
부프레노르핀
메소돈
날트렉손
시장 매력 분석 : 약제 종류별
제7장 세계의 시장 분석과 예측 : 투여 경로별
소개와 정의
주요 조사 결과·발전
시장 금액 예측 : 투여 경로별, 2020-2034년
경구
비경구
시장 매력 분석 : 투여 경로별
제8장 세계의 시장 분석과 예측 : 유통 채널별
소개와 정의
주요 조사 결과·발전
시장 금액 예측 : 유통 채널별, 2020-2034년
병원 약국
소매 약국
온라인 약국
시장 매력 분석 : 유통 채널별
제9장 세계의 시장 분석과 예측 : 지역별
주요 조사 결과
시장 금액 예측 : 지역별, 2020-2034년
북미
유럽
아시아태평양
라틴아메리카
중동 및 아프리카
시장 매력 분석 : 지역별
제10장 북미의 시장 분석과 예측
제11장 유럽의 시장 분석과 예측
제12장 아시아태평양의 시장 분석과 예측
제13장 라틴아메리카의 시장 분석과 예측
제14장 중동 및 아프리카의 시장 분석과 예측
제15장 경쟁 상황
시장 기업 - 경쟁 매트릭스(기업 계층과 규모별)
시장 점유율 분석 : 기업별(2023)
기업 개요
Indivior PLC
Alkermes plc
Orexo AB
Titan Pharmaceuticals, Inc.
Mallinckrodt Pharmaceuticals
BioDelivery Sciences International, Inc.
Viatris Inc.(Mylan N.V.)
Hikma Pharmaceuticals plc
Camurus AB
ksm
영문 목차
영문목차
Opioid Use Disorders Market - Scope of Report
TMR's report on the global opioid use disorders market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global opioid use disorders market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global opioid use disorders market from 2024 to 2034.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the opioid use disorders market.
Market Snapshot
Market Value in 2023
US$ 3.2 Bn
Market Value in 2034
US$ 8.8 Bn
CAGR
9.9%
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global opioid use disorders market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global opioid use disorders market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global opioid use disorders market.
The report delves into the competitive landscape of the global opioid use disorders market. Key players operating in the global opioid use disorders market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global opioid use disorders market profiled in this report.
Key Questions Answered in Global opioid use disorders Market Report:
What is the sales/revenue generated by opioid use disorders across all regions during the forecast period?
What are the opportunities in the global opioid use disorders market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which segment is expected to generate the highest revenue globally in 2034?
Which segment is projected to expand at the highest CAGR during the forecast period?
What are the market positions of different companies operating in the global market?
Opioid Use Disorders Market - Research Objectives and Research Approach
The comprehensive report on the global opioid use disorders market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global opioid use disorders market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global opioid use disorders market.
Table of Contents
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Opioid Use Disorders Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Opioid Use Disorders Market Analysis and Forecast, 2020-2034
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product /Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Opioid Use Disorders Market Analysis and Forecast, by Drug Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Drug Type, 2020-2034
6.3.1. Buprenorphine
6.3.2. Methodone
6.3.3. Naltrexone
6.4. Market Attractiveness Analysis, by Drug Type
7. Global Opioid Use Disorders Market Analysis and Forecast, by Route of Administration
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Route of Administration, 2020-2034
7.3.1. Oral
7.3.2. Parenteral
7.4. Market Attractiveness Analysis, by Route of Administration
8. Global Opioid Use Disorders Market Analysis and Forecast, by Distribution Channel
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Distribution Channel, 2020-2034
8.3.1. Hospital Pharmacies
8.3.2. Retail Pharmacies
8.3.3. Online Pharmacies
8.4. Market Attractiveness Analysis, by Distribution Channel
9. Global Opioid Use Disorders Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2020-2034
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Opioid Use Disorders Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Drug Type, 2020-2034
10.3.1. Buprenorphine
10.3.2. Methodone
10.3.3. Naltrexone
10.4. Market Value Forecast, by Route of Administration, 2020-2034
10.4.1. Oral
10.4.2. Parenteral
10.5. Market Value Forecast, by Distribution Channel, 2020-2034
10.5.1. Hospital Pharmacies
10.5.2. Retail Pharmacies
10.5.3. Online Pharmacies
10.6. Market Value Forecast, by Country, 2020-2034
10.6.1. U.S.
10.6.2. Canada
10.7. Market Attractiveness Analysis
10.7.1. By Drug Type
10.7.2. By Route of Administration
10.7.3. By Distribution Channel
10.7.4. By Country
11. Europe Opioid Use Disorders Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Drug Type, 2020-2034
11.3.1. Buprenorphine
11.3.2. Methodone
11.3.3. Naltrexone
11.4. Market Value Forecast, by Route of Administration, 2020-2034
11.4.1. Oral
11.4.2. Parenteral
11.5. Market Value Forecast, by Distribution Channel, 2020-2034
11.5.1. Hospital Pharmacies
11.5.2. Retail Pharmacies
11.5.3. Online Pharmacies
11.6. Market Value Forecast, by Country/Sub-region, 2020-2034
11.6.1. Germany
11.6.2. U.K.
11.6.3. France
11.6.4. Italy
11.6.5. Spain
11.6.6. Rest of Europe
11.7. Market Attractiveness Analysis
11.7.1. By Drug Type
11.7.2. By Route of Administration
11.7.3. By Distribution Channel
11.7.4. By Country/Sub-region
12. Asia Pacific Opioid Use Disorders Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Drug Type, 2020-2034
12.3.1. Buprenorphine
12.3.2. Methodone
12.3.3. Naltrexone
12.4. Market Value Forecast, by Route of Administration, 2020-2034
12.4.1. Oral
12.4.2. Parenteral
12.5. Market Value Forecast, by Distribution Channel, 2020-2034
12.5.1. Hospital Pharmacies
12.5.2. Retail Pharmacies
12.5.3. Online Pharmacies
12.6. Market Value Forecast, by Country/Sub-region, 2020-2034
12.6.1. China
12.6.2. Japan
12.6.3. India
12.6.4. Australia & New Zealand
12.6.5. Rest of Asia Pacific
12.7. Market Attractiveness Analysis
12.7.1. By Drug Type
12.7.2. By Route of Administration
12.7.3. By Distribution Channel
12.7.4. By Country/Sub-region
13. Latin America Opioid Use Disorders Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Drug Type, 2020-2034
13.3.1. Buprenorphine
13.3.2. Methodone
13.3.3. Naltrexone
13.4. Market Value Forecast, by Route of Administration, 2020-2034
13.4.1. Oral
13.4.2. Parenteral
13.5. Market Value Forecast, by Distribution Channel, 2020-2034
13.5.1. Hospital Pharmacies
13.5.2. Retail Pharmacies
13.5.3. Online Pharmacies
13.6. Market Value Forecast, by Country/Sub-region, 2020-2034
13.6.1. Brazil
13.6.2. Mexico
13.6.3. Rest of Latin America
13.7. Market Attractiveness Analysis
13.7.1. By Drug Type
13.7.2. By Route of Administration
13.7.3. By Distribution Channel
13.7.4. By Country/Sub-region
14. Middle East & Africa Opioid Use Disorders Market Analysis and Forecast
14.1. Introduction
14.2. Key Findings
14.3. Market Value Forecast, by Drug Type, 2020-2034
14.3.1. Buprenorphine
14.3.2. Methodone
14.3.3. Naltrexone
14.4. Market Value Forecast, by Route of Administration, 2020-2034
14.4.1. Oral
14.4.2. Parenteral
14.5. Market Value Forecast, by Distribution Channel, 2020-2034
14.5.1. Hospital Pharmacies
14.5.2. Retail Pharmacies
14.5.3. Online Pharmacies
14.6. Market Value Forecast, by Country/Sub-region, 2020-2034
14.6.1. GCC Countries
14.6.2. South Africa
14.6.3. Rest of Middle East & Africa
14.7. Market Attractiveness Analysis
14.7.1. By Drug Type
14.7.2. By Route of Administration
14.7.3. By Distribution Channel
14.7.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
